Clairvest Invests US$25M in Boca Biolistics

February 21, 2023

Clairvest Group Inc., together with its Clairvest Equity Partners VI co-investment pool, made a US$25 million equity investment in Boca Biolistics, partnering with management (founders Valentin Adia and Michael Morris) who rolled a meaningful portion of their equity. Boca Biolistics is a clinical research organization and biobanking/biomaterials company that procures, stores and sells human biospecimens and also provides in-house analytical laboratory services; the capital will support the company’s next phase of growth and capability expansion.

Buyers
Clairvest Group Inc., Clairvest Equity Partners VI (CEP VI)
Targets
Boca Biolistics
Industry
Biotechnology
Location
Florida, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.